Review and conditions for publication


An abstract is eligible for review when:

  • The abstract is submitted according to the guidelines, on or before the deadline (5 April 2017, extended deadline). 
  • The presenting author has registered and paid for the congress within 2 weeks after submitting the abstract (before 15 April 2017).  

The abstracts submitted will be reviewed for: 

  • Presentation at the congress by means of a poster and e-poster
  • Publication (after the congress) in the congress supplement to the journal European Neuropsychopharmacology

    *An abstract that is not accepted for publication can still be presented at the congress. The titles and 
authors of these abstracts will be listed in the programme booklet, on the online programme and in the ECNP app.  

All submitted abstracts (from registered presenting authors) will be evaluated by a scientific review committee. Authors will be informed of the committee’s decision by e-mail before 1 July 2017 at the latest. There can be no correspondence about the outcome.

Abstracts will be available via our online scientific programme on this website and in the ECNP app.

Condition for publication
Abstracts accepted for publication will be published after the congress in a congress supplement to the journal European Neuropsychopharmacology only if:

  • The presenting author attends the congress
  • The poster is displayed from 09.00-17.00 in the poster area on the day of the poster presentation

  • The presenting author presents the poster on the day and time on which the presentation has been scheduled (please note that checks will be done on-site to make sure posters are displayed and authors are present).

Important: If the presenting author does not meet all three criteria mentioned above, the abstract will not be published in the congress supplement to the journal European Neuropsychopharmacology.

The publisher of European Neuropsychopharmacology holds all publication rights including copyright.